Mark Jaskowski

Title: Mark Jaskowski: Innovator in Bacterial RNA Polymerase Inhibition

Introduction

Mark Jaskowski is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of antibacterial chemistry through his innovative research and patent work. His expertise lies in the development of compounds that inhibit bacterial RNA polymerase, which is crucial for controlling bacterial growth and gene expression.

Latest Patents

Mark Jaskowski holds a patent for "Inhibitors of bacterial RNA polymerase: arylpropanoyl, arylpropenoyl, and arylcyclopropanecarboxyl phloroglucinols." This invention provides compounds that serve as inhibitors of bacterial RNA polymerase. The patent also includes compositions comprising these compounds, methods for their synthesis, and applications for their use. The invention has potential applications in controlling bacterial gene expression, managing bacterial growth, and developing antibacterial therapies. He has 1 patent to his name.

Career Highlights

Mark Jaskowski is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in the field of antibacterial chemistry. His work has garnered attention for its potential impact on public health and the treatment of bacterial infections.

Collaborations

Mark has collaborated with esteemed colleagues such as Richard H Ebright and Joel S Freundlich, contributing to a rich environment of innovation and research.

Conclusion

Mark Jaskowski's contributions to the field of antibacterial chemistry through his innovative patent work highlight the importance of research in combating bacterial infections. His ongoing efforts at Rutgers University continue to pave the way for advancements in this critical area of science.